Oculis Holding AG (OCS) Cash & Equivalents (2021 - 2026)

Oculis Holding AG's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $82.4 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 23.81% year-over-year to $82.4 million in Q1 2026; TTM through Mar 2026 was $82.4 million, a 23.81% increase from a year earlier, with the FY2025 full-year figure at $98.1 million, up 211.45% from the prior year.
• Cash & Equivalents declined to $82.4 million in Q1 2026 per OCS's latest filing, from $101.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $101.8 million in Q4 2025 and bottomed at $20.5 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $46.6 million (2023), against an average of $52.4 million.
• Across the five-year window, Cash & Equivalents slumped 59.08% in 2022 and surged 221.72% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $20.5 million in 2022, then surged by 110.38% to $43.2 million in 2023, then decreased by 26.8% to $31.6 million in 2024, then soared by 221.72% to $101.8 million in 2025, then decreased by 18.97% to $82.4 million in 2026.
• Per Business Quant, the three latest OCS Cash & Equivalents figures stand at $82.4 million (Q1 2026), $101.8 million (Q4 2025), and $58.1 million (Q3 2025).